Solid dispersion system of pranlukast with improved dissolution and method for preparing the same
OwnerSang Deuk Leeinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerSang Deuk Leeinventor
Estimating the term…
A pharmaceutical composition of pranlukast having improved bioavailability is disclosed. The composition is formulated as a solid dispersion, preferably for oral administration. In one embodiment, the invention comprises an amount of pranlukast uniformly dispersed in an inert polymer carrier comprising at least one of hydroxypropylmethylcellulose or hydroxypropylcellulose. In another embodiment, the composition further comprises an amount of hydroxypropylmethylcellulose phthalate-50. A method for preparing the composition, an oral formulation comprising the composition, and methods of treating bronchial asthma and allergic rhinitis with the composition are also disclosed.
A pharmaceutical composition comprising an amount of pranlukast (4-oxo-8-[4-(4-phenylbutoxy)benzoyl-amino]-2-(tetrazol-5-yl)-4H-1-benzopyran hemihydrate) uniformly dispersed in a solid state inert polymer carrier comprising at least one of hydroxypropylcellulose (“HPC”) or hydroxypropylmethylcellulose (“HPMC”).
A solid dispersion formulation for oral administration consisting essentially of a pharmaceutical composition comprising an amount pranlukast uniformly dispersed in a solid state inert polymer carrier comprising at least one of HPC or HPMC.
A method for preparing a solid dispersion formulation consisting essentially of a pharmaceutical composition comprising pranlukast uniformly dispersed in a solid state inert polymer carrier comprising at least one of HPC or HPMC, the method comprising:
Dependencies are inferred from the claim text.